These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 9209198

  • 1. Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density.
    Chesnut CH, Bell NH, Clark GS, Drinkwater BL, English SC, Johnson CC, Notelovitz M, Rosen C, Cain DF, Flessland KA, Mallinak NJ.
    Am J Med; 1997 Jan; 102(1):29-37. PubMed ID: 9209198
    [Abstract] [Full Text] [Related]

  • 2. The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation.
    Rosen CJ, Chesnut CH, Mallinak NJ.
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1904-10. PubMed ID: 9177404
    [Abstract] [Full Text] [Related]

  • 3. Early changes in biochemical markers of bone turnover predict bone mineral density response to antiresorptive therapy in Korean postmenopausal women with osteoporosis.
    Kim SW, Park DJ, Park KS, Kim SY, Cho BY, Lee HK, Shin CS.
    Endocr J; 2005 Dec; 52(6):667-74. PubMed ID: 16410657
    [Abstract] [Full Text] [Related]

  • 4. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial.
    Marcus R, Holloway L, Wells B, Greendale G, James MK, Wasilauskas C, Kelaghan J.
    J Bone Miner Res; 1999 Sep; 14(9):1583-95. PubMed ID: 10469288
    [Abstract] [Full Text] [Related]

  • 5. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.
    Guo CY, Thomas WE, al-Dehaimi AW, Assiri AM, Eastell R.
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3487-91. PubMed ID: 8855790
    [Abstract] [Full Text] [Related]

  • 6. The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women.
    Chaki O, Yoshikata I, Kikuchi R, Nakayama M, Uchiyama Y, Hirahara F, Gorai I.
    J Bone Miner Res; 2000 Aug; 15(8):1537-44. PubMed ID: 10934652
    [Abstract] [Full Text] [Related]

  • 7. Effects of alendronate combined with hormone replacement therapy on osteoporotic postmenopausal Chinese women.
    Tseng LN, Sheu WH, Ho ES, Lan HH, Hu CC, Kao CH.
    Metabolism; 2006 Jun; 55(6):741-7. PubMed ID: 16713432
    [Abstract] [Full Text] [Related]

  • 8. The effect of hormone replacement therapy in postmenopausal women on urinary C-telopeptide and N-telopeptide of type I collagen, new markers of bone resorption.
    Taga M, Uemura T, Minaguchi H.
    J Endocrinol Invest; 1998 Mar; 21(3):154-9. PubMed ID: 9591210
    [Abstract] [Full Text] [Related]

  • 9. Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alendronate in postmenopausal Japanese women with osteoporosis.
    Iwamoto J, Takeda T, Sato Y, Uzawa M.
    J Bone Miner Metab; 2005 Mar; 23(3):238-42. PubMed ID: 15838627
    [Abstract] [Full Text] [Related]

  • 10. Effects of alendronate and hormone replacement therapy, alone and in combination, on bone mass and markers of bone turnover in elderly women with osteoporosis.
    Eviö S, Tiitinen A, Laitinen K, Ylikorkala O, Välimäki MJ.
    J Clin Endocrinol Metab; 2004 Feb; 89(2):626-31. PubMed ID: 14764773
    [Abstract] [Full Text] [Related]

  • 11. Bone mineral density response to estrogen replacement in frail elderly women: a randomized controlled trial.
    Villareal DT, Binder EF, Williams DB, Schechtman KB, Yarasheski KE, Kohrt WM.
    JAMA; 2001 Aug 15; 286(7):815-20. PubMed ID: 11497535
    [Abstract] [Full Text] [Related]

  • 12. Differences in bone resorption after menopause in Japanese women with normal or low bone mineral density: quantitation of urinary cross-linked N-telopeptides.
    Taguchi Y, Gorai I, Zhang MG, Chaki O, Nakayama M, Minaguchi H.
    Calcif Tissue Int; 1998 May 15; 62(5):395-9. PubMed ID: 9541516
    [Abstract] [Full Text] [Related]

  • 13. The values of urinary NTx in postmenopausal women undergoing HRT; the role of additional alendronate therapy.
    Posaci C, Altunyurt S, Islekel H, Saygili U, Altekin E, Onvural A, Onvural B.
    Maturitas; 2002 Aug 30; 42(4):281-6. PubMed ID: 12191850
    [Abstract] [Full Text] [Related]

  • 14. Urinary N-telopeptide levels discriminate normal, osteopenic, and osteoporotic bone mineral density.
    Schneider DL, Barrett-Connor EL.
    Arch Intern Med; 1997 Jun 09; 157(11):1241-5. PubMed ID: 9183236
    [Abstract] [Full Text] [Related]

  • 15. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women.
    Lindsay R, Gallagher JC, Kleerekoper M, Pickar JH.
    JAMA; 1997 Jun 09; 287(20):2668-76. PubMed ID: 12020302
    [Abstract] [Full Text] [Related]

  • 16. The decrease in serum bone-specific alkaline phosphatase predicts bone mineral density response to hormone replacement therapy in early postmenopausal women.
    Dresner-Pollak R, Mayer M, Hochner-Celiniker D.
    Calcif Tissue Int; 2000 Feb 09; 66(2):104-7. PubMed ID: 10652956
    [Abstract] [Full Text] [Related]

  • 17. Determinants of one-year response of lumbar bone mineral density to alendronate treatment in elderly Japanese women with osteoporosis.
    Iwamoto J, Takeda T, Sato Y, Uzawa M.
    Yonsei Med J; 2004 Aug 31; 45(4):676-82. PubMed ID: 15344210
    [Abstract] [Full Text] [Related]

  • 18. Effect of walking exercise on bone metabolism in postmenopausal women with osteopenia/osteoporosis.
    Yamazaki S, Ichimura S, Iwamoto J, Takeda T, Toyama Y.
    J Bone Miner Metab; 2004 Aug 31; 22(5):500-8. PubMed ID: 15316873
    [Abstract] [Full Text] [Related]

  • 19. Effect of teriparatide [rhPTH(1-34)] on BMD when given to postmenopausal women receiving hormone replacement therapy.
    Ste-Marie LG, Schwartz SL, Hossain A, Desaiah D, Gaich GA.
    J Bone Miner Res; 2006 Feb 31; 21(2):283-91. PubMed ID: 16418784
    [Abstract] [Full Text] [Related]

  • 20. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.
    Heikkinen AM, Parviainen M, Niskanen L, Komulainen M, Tuppurainen MT, Kröger H, Saarikoski S.
    J Clin Endocrinol Metab; 1997 Aug 31; 82(8):2476-82. PubMed ID: 9253321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.